Comprehensive review of patients with hypercoagulable state in rheumatoid arthritis and strategies to reduce readmission rates: A retrospective cohort study based on protective exploration of traditional Chinese medicine

被引:0
|
作者
Li, Yang [1 ,2 ]
Liu, Jian [1 ,3 ]
Hu, Yuedi [1 ,2 ]
Cong, Chengzhi [1 ,2 ]
Chen, Yiming [1 ,2 ]
Wang, Fanfan [1 ,2 ]
机构
[1] Anhui Univ Chinese Med, Affiliated Hosp 1, Dept Rheumatol, Hefei 230031, Peoples R China
[2] Anhui Univ Chinese Med, Clin Med Sch 1, Hefei, Peoples R China
[3] Anhui Acad Chinese Med, Inst Rheumatol, Hefei, Peoples R China
关键词
hypercoagulable state; readmission; retrospective cohort study; rheumatoid arthritis; traditional Chinese medicine; XINFENG CAPSULE; INFLAMMATION;
D O I
10.1097/MD.0000000000040890
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study aimed to investigate the effect of traditional Chinese medicine (TCM) intervention on the risk of readmission and laboratory indicators in patients with rheumatoid arthritis hypercoagulable state. In the retrospective cohort design, patients with RA hospitalized between June 2013 and June 2021 at the First Affiliated Hospital of Anhui University of Chinese Medicine were followed up by telephone. Propensity score matching (PSM) was used to balance deviations in baseline information between patients in the hypercoagulable (HC) and non-hypercoagulable (Non-HC) groups, with exposure defined as receiving TCM treatment for >= 1 month. Cox proportional hazards model and Kaplan-Meier survival curves were employed to determine the factors influencing the readmission of RA-HC patients. Mantel test and association rule analysis was used to explore the relationship between the included factors and laboratory indicators. A total of 1169 cases were successfully followed up, including 831 RA-HC patients. 1:2 PSM yielded 311 patients in the non-HC group versus 535 patients in the HC group. We observed that the incidence of readmission and surgical treatment was significantly higher in the HC group than in the non-HC group, while the incidence of readmission, surgical treatment, and all-cause mortality was much lower in the exposed group than in the non-exposed group (all P < .05). Based on the Cox proportional risk model, we identified age above 60 years, Sjogren's syndrome, neutrophil count, and neutrophil-lymphocyte ratio (NLR) as risk factors for readmission, with TCM playing a protective role. The Kaplan-Meier survival curves further showed that the risk of readmission in the high-exposure subgroup was markedly lower than that of the low-exposure subgroup. Furthermore, the Mantel test highlights an intrinsic correlation between coagulation markers and other markers such as erythrocyte sedimentation rate (ESR) and hypersensitive c-reactive protein (hs-CRP), which are dramatically influenced by gender, age, etc. In addition, association rule analysis revealed a strong correlation between TCM and non-readmission, as well as improvement in rheumatoid factor, hs-CRP, ESR, platelet count, and NLR in RA-HC patients. As a promising therapeutic strategy, TCM with sufficient intensity and duration interventions can effectively reduce the risk of readmission and relieve laboratory indicators in RA-HC patients.
引用
收藏
页数:15
相关论文
共 25 条
  • [1] Traditional Chinese Medicine Is Associated with Reduced Risk of Readmission in Rheumatoid Arthritis Patients with Anemia: A Retrospective Cohort Study
    Sun, Yanqiu
    Liu, Jian
    Xin, Ling
    Wen, Jianting
    Zhou, Qin
    Chen, Xiaolu
    Ding, Xiang
    Zhang, Xianheng
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [2] Traditional Chinese Medicine Is Associated with Reduced Risk of Readmission in Rheumatoid Arthritis Patients with Anemia: A Retrospective Cohort Study
    Sun, Yanqiu
    Liu, Jian
    Xin, Ling
    Wen, Jianting
    Zhou, Qin
    Chen, Xiaolu
    Ding, Xiang
    Zhang, Xianheng
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [3] Chinese herbal medicine reduces the risk of readmission in patients with rheumatoid arthritis combined with hyperlipidemia: A population-based retrospective cohort study
    He, Mingyu
    Liu, Jian
    Fang, Yanyan
    Wang, Fanfan
    Li, Xu
    Han, Qi
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 25 (01)
  • [4] A survey of traditional Chinese medicine use among rheumatoid arthritis patients: a claims data–based cohort study
    Ming-Chi Lu
    Hanoch Livneh
    Lei-Mei Chiu
    Ning-Sheng Lai
    Chia-Chou Yeh
    Tzung-Yi Tsai
    Clinical Rheumatology, 2019, 38 : 1393 - 1400
  • [5] A survey of traditional Chinese medicine use among rheumatoid arthritis patients: a claims data-based cohort study
    Lu, Ming-Chi
    Livneh, Hanoch
    Chiu, Lei-Mei
    Lai, Ning-Sheng
    Yeh, Chia-Chou
    Tsai, Tzung-Yi
    CLINICAL RHEUMATOLOGY, 2019, 38 (05) : 1393 - 1400
  • [6] Traditional Chinese Medicine Compound Preparations Are Associated with Low Disease-Related Complication Rates in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study of 11,074 Patients
    Fang, Yanyan
    Liu, Jian
    Xin, Ling
    Chen, Xiaolu
    Ding, Xiang
    Han, Qi
    He, Mingyu
    Li, Xu
    Sun, Yanqiu
    Wang, Fanfan
    Wang, Jie
    Wang, Xin
    Wen, Jianting
    Zhang, Xianheng
    Zhou, Qin
    Zhang, Junru
    BIOMED RESEARCH INTERNATIONAL, 2023, 2023
  • [7] Traditional Chinese medicine use may reduce medical utility in patients with asthma: a nationwide population-based retrospective cohort study
    Liao, P. F.
    Wang, Y. T.
    Wang, Y. H.
    Chiou, J. Y.
    Wei, J. C. C.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2021, 114 (12) : 857 - 864
  • [8] The effect of long-term traditional Chinese medicine treatment on extra-articular lesions of rheumatoid arthritis patients based on propensity score matching: A retrospective cohort study
    Wen, Jianting
    Liu, Jian
    Wan, Lei
    Xin, Ling
    Sun, Yue
    Wang, Fanfan
    HELIYON, 2024, 10 (01)
  • [9] Association between use of Chinese herbal medicine and depression risk in patients with rheumatoid arthritis: A nationwide retrospective cohort study
    Li, Hsin-Hua
    Livneh, Hanoch
    Yeh, Chia-Chou
    Guo, How-Ran
    Lai, Ning-Sheng
    Lu, Ming-Chi
    Tsai, Tzung-Yi
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (06) : 986 - 994
  • [10] Traditional Chinese medicine may be associated with a reduced risk of recurrent exacerbation in patients with rheumatoid arthritis: A matched cohort study based on 1383 individuals
    Wang, Fanfan
    Liu, Jian
    Fang, Yanyan
    Li, Xu
    He, Mingyu
    Han, Qi
    HELIYON, 2023, 9 (04)